Δευτέρα 5 Μαρτίου 2018

Antitumor and radiosensitizing effects of SKLB-163, a novel benzothiazole-2-thiol derivative, on nasopharyngeal carcinoma by affecting the RhoGDI/JNK-1 signaling pathway

SKLB-163 is a novel benzothiazole-2-thiol derivative with antitumor activities. This study investigated the effects of SKLB-163 on nasopharyngeal carcinoma (NPC) and its mechanisms.

http://ift.tt/2FdX5RD

Δεν υπάρχουν σχόλια:

Δημοσίευση σχολίου